Parathyroid hormone-related protein (PTHrP) is widely expressed in normal adult and fetal tissues, where it acts in an autocrine/paracrine fashion, stimulates growth and differentiation, and shares early response gene characteristics. Since recovery from renal injury is associated with release of local growth factors, we examined the expression and localization of PTHrP in normal and ischemic adult rat kidney. Male SpragueDawley rats underwent complete bilateral renal artery occlusion for 45 min, followed by reperfusion for 15 min., and 2,6, 24, 48, and 72 h. Renal PTHrP mRNA levels, when compared with sham-operated animals, increased twofold after ischemia, and peaked within 6 h after reperfusion. PTH receptor, j-actin, and cyclophilin mRNA levels all decreased after ischemia. PTHrP immunohistochemical staining intensity increased in proximal tubular cells after ischemia, changing its location from diffusely cytoplasmic to subapical by 24 h after reperfusion. In addition, PTHrP localized to glomerular epithelial cells (visceral and parietal), but not to mesangial cells. PTHrP and PTH stimulated proliferation two-to threefold in cultured mesangial cells. We conclude that PTHrP mRNA and protein production are upregulated after acute renal ischemic injury, that PTHrP is present in glomerulus and in both proximal and distal tubular cells, and that PTHrP stimulates DNA synthesis in mesangial cells. The precise functions of PTHrP in normal and injured kidney remain to be defined. (J. Clin. Invest. 1993. 
Introduction
Parathyroid hormone-related protein (PTHrP)' is the peptide hormone responsible for most instances of humoral hypercalcemia of malignancy (1) (2) (3) . While many malignancies overexpress PTHrP, these peptides are also produced by a wide variety of normal tissues, including the central nervous system, pancreatic islets, epidermal keratinocytes, adrenal cortex and medulla, lactating breast, placenta, and vascular smooth muscle (1) (2) (3) . PTHrP is additionally expressed in the fetus, where it is present in virtually every organ system and is believed to be essential for normal growth and development (1) (2) (3) (4) . PTHrP is believed to act in an autocrine and/or paracrine fashion in these tissues, although its exact biological function has not been clearly established. Its extraordinarily wide tissue distribution, its highly conserved amino acid sequence (1) (2) (3) , and the observation that "knockout" of the PTHrP gene in transgenic mice is lethal (5) collectively suggest that PTHrP has important physiological roles.
In addition, PTHrP has been detected in both adult and fetal kidney. In kidney sections from the human and rat fetus, PTHrP has been identified histochemically in glomerulus and tubules (proximal, distal, collecting tubule) until mid to late gestation, at which time glomerular staining disappears while tubular staining remains (6) (7) (8) . Northern blot analysis has shown PTHrP mRNA present in human kidney as early as 10 wk of gestation (6) , and PTHrP immunoreactivity has been reported in acid-urea extracts of adult kidney (9) . The precise physiological role ofPTHrP in the kidney is not clear, although it has been shown to potentiate growth in cultured madindarby canine kidney distal renal tubular cells (10) and in cultured human renal carcinoma cells ( 1 1). PTHrP has also been shown to have TGF-f3-like effects ( 12) and to share characteristics with the early response gene family ( 13, 14) . To date, no study has addressed the localization or functional role of PTHrP in normal renal physiology or in tubular or glomerular disease. Since renal injury and subsequent recovery are associated with the enhanced expression and action ofa number of other cytokines and growth factors, since PTHrP is expressed during renal development, and since PTHrP has been credited with growth factor-like activity in a number of tissues, including the kidney, we have explored the expression, localization, and action of PTHrP in a well-characterized model of renal ischemia, acute tubular necrosis, and eventual recovery.
Methods
Renal ischemia model. This model has been described in detail previously ( 15), and has been approved by the Yale Animal Use Committee. Male Sprague-Dawley rats weighing 225-300 g were used for all experiments and were allowed free access to water and standard rat chow before anesthesia. Animals undergoing renal ischemia were anesthetized with pentobarbital sodium (50 mg/kg i.p.) or thiobutabarbital sodium (Inectin; 80 mg/kg i.p.), placed on a warming board, and maintained at 36.5-37.5°C. After catheterization ofthe external jugular vein, the kidneys were exposed through an abdominal incision, and the aorta and right renal artery dissected free from surrounding tissue. Animals were then heparinized (500 U/kg i.v.) for 10 min. Bilateral renal ischemia was then induced with a vascular clamp placed across the aorta just proximal to the left renal artery and with a Silastic sling looped around the right renal artery. Clamps were removed after 45 min ofcomplete renal artery occlusion, and uniform reperfusion ofthe kidneys was visually confirmed. Isotonic saline was administered to replace surgical fluid loss (2% body weight), and maintenance fluids of 1.2 ml/h were infused for recovery periods of > 15 min, with free access to water for those animals with recovery periods of at least 24 h.
Kidneys were reperfused for 15 min, and 2, 6, 24, 48, and 72 h. Animals were killed at each of these reflow time points; both kidneys were then harvested, immediately frozen in liquid nitrogen, and stored at -70'C until RNA extraction was performed. Sham-operated animals underwent identical procedures with the exception of renal artery occlusion. Kidneys were harvested from sham-operated animals at times equivalent to the 2-and 6-h reflow periods. Kidney RNA extraction, Northern blot analysis, and RNase protection assay. Frozen tissue (0.3-0.5 g) was homogenized with a Tissuemizer (Tekmar) in 4 M guanidine isothiocyanate and 0.1 M 2-mercaptoethanol. Total RNA was extracted from whole rat kidney at each reflow time point using the guanidine isothiocyanate/guanidine hydrochloride variation of the methods of Chirgwin et al. (16) and of Chomczynski and Sacchi (17) . For Northern blot analysis, 20 ,g of total RNA was analyzed on 1% agarose/formaldehyde gels, then transferred onto nylon-supported nitrocellulose filters and fixed at 80'C for 1 h. Prehybridization was performed for 2-4 h at 420C in a 50% formamide solution containing 6.6x SSC (1 M NaCl, 0.1 M Na Citrate), 0.1% SDS, 5x Denhardt's (0.1% Ficoll, 0.1% polyvinyl pyrrolidone, 0.1% BSA), 0.01 M EDTA, and 200 tg/ml ofdenatured salmon sperm DNA. Filters were hybridized overnight under the same conditions using a random-primed rat PTH/PTHrP receptor cDNA probe encompassing the first 2, 100 nucleotides ofthe coding region, generously provided by Drs. H. Jueppner, A-B Abou-Samra, and G. V. Segre ( 18) . After hybridization, filters were washed as indicated in the legend to Fig. 3 , then analyzed by autoradiography. Filters were stripped by washing at 650C in a solution of 15 ml formamide, 3 ml 0.1 X SSC/ 1% SDS, and 12 ml DEPC-treated water, and were rehybridized under similar conditions to actin and cyclophilin probes. Differences in RNA loading were analyzed by hybridizing the filters with an oligonucleotide probe to the 28S subunit of ribosomal RNA. All conditions for prehybridization, probe labeling, hybridization, and filter washing were performed as described by Barbu and Dautry ( 19 Mesangial cell (MC) isolation and culture. MCs were isolated and cultured from perfused kidneys obtained from young male rats by previously described procedures (23) . For these experiments we used subcultures of the second to eighth passages of MCs grown at 370C in 5% CO2 and 95% air. The identity of the MCs was established by several criteria. Morphologic evaluation of MC cultures revealed a homogeneous population of stellate or fusiform cells with prominent intracellular fibrillar structures. These morphologic features of cultured MCs have been described previously (24) . In addition, we used indirect immunocytochemistry with both rabbit IgG antibodies directed against vascular smooth muscle myosin and fluorescein isothiocyanate-conjugated mouse IgG antibodies directed to IgG and Thy-l.l. These studies showed uniformly strong positive staining ofdistinct longitudinal fibrils in all observed cells. This staining pattern ofglomerular cell outgrowth is considered to be indicative of MCs (24, 25) . Subcultured MCs were grown in 75-cm2 flasks in Dulbecco's minimum essential medium that contained 10% FCS, 5 ,g/ml insulin, 10 mM L-glutamine, 400 ng/ml penicillin, 500 ng/ml streptomycin, and 25 mM HCO3.
MC proliferation assay. For PTHrP mRNA levels, we questioned whether this would result in changes in the level of PTH receptor mRNA expression in the rat kidney. As seen in Fig. 3 A, PTH receptor mRNA levels decreased within the first 2 h after reperfusion. By 72 h the PTH receptor mRNA levels had not returned to baseline. To document that the decrease in PTH receptor mRNA was not a result of sample loading differences, the filter was reprobed for fl-actin and cyclophilin. As seen in Fig. 3 , B and C, both (3-actin and cyclophilin mRNA levels also decreased after ischemic injury, reaching nadirs between 2 and 6 h after reperfusion. When the same filter was probed for 28S ribosomal RNA (Fig. 3 D) , relatively minor differences in the amount of 28S RNA were observed on the filter at the different time points. Thus, only a portion of the fall in PTH receptor mRNA could be accounted for by loading differences or RNA degradation. These considerations make the increment in PTHrP mRNA shown in Figs. 1 and 2 more striking.
Immunohistochemical localization of PTHrP. Since
PTHrP mRNA was found to be present in RNA prepared from whole normal rat kidney and its production stimulated by ischemic injury, and since the location of PTHrP in the adult rat kidney is unknown, we attempted to localize the source of PTHrP in the rat kidney. Immunohistochemistry was performed on frozen sections of PLP-fixed sham-operated and ischemic kidneys using region-specific, affinity-purified anti- T   2h 6h 24h 48h 72h Figure 2 . Densitometric analysis of PTHrP mRNA levels after renal ischemia as determined in multiple experiments analogous to those shown in Fig. 1 . Bars indicate the ratio of PTHrP mRNA to cyclophilin mRNA as assessed using densitometry after RNase protection analysis. Each bar represents the mean value of mRNA prepared from six kidneys for the sham, 15-min, and 2-, 6-, and 24-h time points, and from two kidneys for the remaining two time points. *P = 0.025; **P= 0.004. D 28S- Bl-actin, and cyclophilin mRNA levels all fall at 2-6 h after reperfusion.
bodies to PTHrP regions 1-36 and 37-74. As seen in Fig. 4 A, addition of anti-PTHrP (37-74) antibody to sections from sham-operated animals reveals prominent glomerular staining. The glomerular staining is confined to epithelial cells, both visceral and parietal, without mesangial cell or endothelial cell staining (Fig. 4, A and B) . A similar glomerular pattern was observed using anti-PTHrP (1-36) antibody. The intensity and pattern of glomerular staining was corroborated by confocal microscopy (Fig. 4 C) ( 1-36) peptides (10-6 M) eliminated the glomerular epithelial cell staining (Fig. 4 D) . PTHrP was also found to be present in both proximal and distal tubular cells when examined by conventional fluorescent microscopy (Fig. 4, E and F) . In contrast to the glomerular epithelial cell staining, however, the tubular pattern of fluorescence was altered after ischemia (Fig. 5) . In sham-operated animals, proximal tubular localization of PTHrP by confocal microscopy was primarily in a vesicular pattern within the cytoplasm (Fig. 5 B) . After 6 h of reperfusion, the intensity of PTHrP staining was increased and was now present in a diffuse cytoplasmic distribution (Fig. 5 C) . By 24 h after ischemic injury, the diffuse cytoplasmic staining remained, but an additional vesicular staining pattern was present in a subapical location (Fig. 5 D) . As with glomerular staining, this tubular staining disappeared when antibody was incubated with excess ( 10-6 M) PTHrP (37-74) peptide. Identical tubular and glomerular staining patterns were seen with addition of antiPTHrP ( 1-36) antibody (not shown).
Cellular proliferation. Since MCs are stimulated to proliferate by a number of cytokines and hormones, and given the presence of PTHrP within the glomerulus, the question was raised as to whether PTHrP ( 1-36) would also act as a mitogen in mesangial cells. These results are shown in Fig. 6 . PTHrP (1-36) at 7 X 10-9 M stimulated a two-to threefold increase in [3H]thymidine incorporation in cultured MCs. MCs exposed to 7 X 10 -9 M bPTH ( 1-34) showed a similar response. These findings were confirmed using direct cell counting ofMC numbers from parallel experiments, as indicated in the legend to 
Discussion
The recovery phase of acute renal failure has recently become an area of considerable interest. Much investigation has focused on the regenerative phase in renal tubular cells, and on the changes in gene expression that result in increased production oflocal cytokines and growth factors that contribute to the regenerative process (26, 27) . For example, the renal synthesis ofEGF and IGF-I is altered after ischemic injury, and administration of these agents just before or during ischemia results in an enhanced renal tubular proliferative response, a lower peak blood urea nitrogen and serum creatinine, and a more rapid return to normal renal function compared with untreated ani- mals (28, 29) . These growth factors are synthesized primarily by renal tubular cells (26, 27) , although glomerular cells are now known to contribute to the repair process as well (26) . In addition to increases in mRNA levels and growth effects of these cytokines, rapid increases in the levels of early response gene mRNAs (c-fos, Egr-l and c-myc) occur after acute renal injury, presumably intended to stimulate the transcription of other factors involved in repair (26, 27) .
PTHrP has been shown to have growth factor-like effects ( 10-12, 30, 31 ) , to act as an early response gene in some tissues ( 13, 14) , and to be present in fetal kidney (6) (7) (8) , suggesting that PTHrP may play a role in the recovery from renal ischemia and acute tubular necrosis. We therefore studied the role of PTHrP in the adult kidney after an acute ischemic insult. The mRNA levels of most proteins and peptide hormones decrease in the rat kidney after ischemia. This is believed to be due to the generalized reduction in gene transcription rates in ischemic and recovering kidney (32), as well as to enhanced mRNA degradation. This generalized reduction in steady-state mRNA levels in the kidney was mirrored in this study by the reduction in both actin and cyclophilin mRNAs after ischemia. In marked contrast, however, PTHrP mRNA increased twofold after ischemic injury, and increased in a time frame similar to other known renal growth factors (26 [34] [35] [36] . These changes are believed to relate to the location of cellular injury and to early attempts at cellular repair ( 15, 26) . From this perspective, it is important to note that growth effects of PTHrP have been observed in cultured MDCK (i.e., canine distal tubular) cells and in renal carcinoma cells (10, 11) , as they have been in many nonrenal tissues. The enhanced staining of PTHrP within the tubules at 6 and 24 h after injury, together with the documented growth factor-like effects of PTHrP, suggest that PTHrP could play a regulatory role in growth or differentiation during tubular regeneration. The apical localization at 24 h may additionally reflect the movement of PTHrP toward the most severely injured portion of the tubule in order to contribute to the repair process, or may represent packaging into lysosomes for eventual apical secretion after providing its physiological effect. It is interesting to note that these changes are a mirror image to those observed with heat shock protein-72, where the peptide is located apically at early time points after renal injury and then localizes to the basolateral membrane by 24 h into the repair process ( 15). Finally, PTHrP was also identified in normal (i.e., sham-operated) renal tubular cells, suggesting a role for the peptide in normal adult renal tubule function in the rat.
The most unexpected observation in this study was the dramatic PTHrP staining in the glomerulus. Both visceral and parietal epithelial cells showed prominent PTHrP staining, while mesangial cells were almost completely negative. This was substantiated by confocal microscopy. Receptors for PTH are known to be present on both mesangial and epithelial cells (37, 38) ( 1-3) .
In this study, PTHrP was shown to be both present in the glomerulus and to have an effect within glomerular cells. Without in situ hybridization data using PTHrP probes, however, these findings do not exclude the possibility that circulating PTHrP is trapped or concentrated by these cells. These findings appear to extend the observations ofothers indicating that communication may exist between the different glomerular cell types (39) , and suggests that PTHrP may have an autocrine or paracrine role in these cells. It is interesting to note that in most histochemical analyses of PTHrP in rat and human fetal kidney, glomerular staining decreases or completely disappears by late gestation, while tubular staining remains prominent (6) (7) (8) . The prominent glomerular findings in this study may represent differences in antibody affinity, epitope recognition sites, or in fixation methods.
In conclusion, PTHrP mRNA is increased after acute renal ischemic injury. PTHrP is present in the glomerulus and in both proximal and distal tubular cells, and stimulates DNA synthesis in mesangial cells. PTHrP is believed to have critical functions involving growth and development, transepithelial calcium transport, and smooth muscle regulation in an everexpanding list of tissues. These functions are only beginning to be explored. This study provides the first evidence of a role for PTHrP in the normal glomerulus and in injured kidney. Future studies will need to be performed in order to define the precise physiological and pathophysiological functions of this peptide.
